| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Alfuzosin | Alfuzosin EP Impurity A (Free Base) | VE006693 | View CAS 98902-36-4 |
| Alfuzosin | Alfuzosin EP Impurity A (HCl salt) | VL259002 | View CAS 98902-29-5 |
| Alfuzosin | Alfuzosin EP Impurity B | VL259008 | View CAS 23680-84-4 |
| Alfuzosin | Alfuzosin EP Impurity C | VL259009 | View CAS 72104-34-8 |
| Alfuzosin | Alfuzosin EP Impurity C (Free Base) | VE006699 | View CAS 98902-34-2 |
| Alfuzosin | Alfuzosin EP Impurity D | VL259003 | View CAS 81403-69-2 |
| Alfuzosin | Alfuzosin EP Impurity D (Free Base) | VE006695 | View CAS 76362-29-3 |
| Alfuzosin | Alfuzosin EP Impurity E | VL259004 | View CAS 1026411-59-5 |
| Alfuzosin | Alfuzosin EP Impurity E (free base) | VL259012 | View CAS 1026411-59-5 |
| Alfuzosin | Alfuzosin EP Impurity F | VL259005 | View CAS 19216-53-6 |
| Alfuzosin | Alfuzosin EP Impurity G | VL259010 | View CAS 928780-95-4 |
| Alfuzosin | Alfuzosin Hydrochloride | VL259001 | View CAS 81403-68-1 |
| Alfuzosin | Alfuzosin Impurity 2 | VL259014 | View |
| Alfuzosin | Alfuzosin Impurity 4 | VE0012085 | View |
| Alfuzosin | Alfuzosin Impurity 5 | VE0012086 | View |
| Alfuzosin | Alfuzosin-D3 | DVE00130 | View CAS 1006724-55-5 |
| Alfuzosin | (±)-Alfuzosin D7 HCl (tetrahydrofuroyl D7) | DVE0080 | View CAS 1276197-14-8 |
Alfuzosin Related Compound
Benign enlargement of the prostate is a common condition in men as they age. The prostate gland is found beneath the bladder.
References
- van Moorselaar, R. Jeroen A., et al. “Alfuzosin 10 Mg Once Daily Improves Sexual Function in Men with Lower Urinary Tract Symptoms and Concomitant Sexual Dysfunction.” BJU International, vol. 95, no. 4, Mar. 2005, pp. 603–8, https://doi.org/10.1111/j.1464-410x.2005.05347.x. Accessed 20 Feb. 2023.
- Alfuzosin (Oral Route) Side Effects – Mayo Clinic.” Mayoclinic.org, 2023, www.mayoclinic.org/drugs-supplements/alfuzosin-oral-route/side-effects/drg-20061611?p=1#:~:text=This%20can%20cause%20problems%20with,urine%20or%20decrease%20the%20symptoms. Accessed 20 Feb. 2023.
FAQ
What is the therapeutic category of alfuzosin?
Alfuzosin belongs to the class of medicines known as alpha-blockers. It works by relaxing the muscles in the prostate and bladder, making it easier for urination to flow.
Does alfuzosin improve erectile dysfunction?
It may potentially enhance sexual function in males who have erectile dysfunction and/or ejaculatory dysfunction.
Does alfuzosin cause more urination?
This might result in urination issues such as the desire to urinate frequently, a weak stream when urinating, or the sense of not being able to completely empty the bladder. Alfuzosin relaxes the muscles in the prostate and the bladder opening. This may assist enhance urine flow or alleviate discomfort.
